Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer-Reference-Cited by-同舟云学术

Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer

Published:2006-09 Issue:3 Volume:102 Page:447-452
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Paulsen Torbjørn,Kærn Janne,Kjærheim Kristina,Haldorsen Tor,Tropé Claes

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference43 articles.

1. Carcinoma of the ovary;Heintz;J. Epidemiol. Biostat.,2001

2. Unpublished data from Cancer Registry of Norway. http://www.kreftregisteret.no/frame.htm?forekomst_og_overlevelse_2001/ovary/incidence.htm. Cancer Registry of Norway; 2005.

3. Symptoms and referral of women with epithelial ovarian tumors;Paulsen;Int. J. Gynaecol. Obstet.,2005

4. Cancer in Norway 2002. Cancer Registry of Norway; 2005.

5. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades;Barnholtz-Sloan;Am. J. Obstet. Gynecol.,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of the Time Interval between Surgery and Postoperative Adjuvant Chemotherapy in Epithelial Carcinoma of the Ovary;Hong Kong Journal of Radiology;2021-03-25

2. Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare;Cancers;2020-05-20

3. Return to intended oncologic therapy: a potentially valuable endpoint for perioperative research in cancer patients?;British Journal of Anaesthesia;2020-05

4. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;International Journal of Gynecologic Cancer;2019-05

5. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Annals of Oncology;2019-05